Clinical Trials

Purpose

The Clinical Trials Programme enables individuals who have completed their academic training to conduct at any time patient-oriented clinical research within a temporary project.

The programme provides funding for interventional clinical studies, including feasibility studies (phase II) and interventional trials (phase III). The aim is to prove the efficacy of a new therapeutic, diagnostic or prognostic method. For all studies, high scientific quality and originality as well as clinical relevance are required.

The programme also funds observational trials, provided that the study investigates a highly relevant research question that cannot demonstrably be answered using an interventional design.

Further information on the types of studies can be found in the programme guidelines.

• Interner Link Guidelines -- Clinical Trials Programme

Proposal Requirements

High international scientific quality and originality; clinical relevance

Type and Extent of Funding

Funding for staff, scientific equipment, consumables, travel, other costs (such as costs of monitoring, insurance for patients and/or test persons, recruiting costs, costs of supervisory boards (only costs related to the trial may be requested), payments to patients, third party services)

Funding Duration

The funding duration for feasibility studies is a maximum of 36 months; renewal proposals are not possible.

The funding duration of interventional trials and observational trials is initially 36 months. For longer studies, a renewal proposal may be submitted subsequently.

Eligibility Requirements

Researchers in Germany who have completed their academic training (a doctorate as a rule) are eligible.